Assignee
ADOCIA
FR33 patents
Top patents by PatentIndex Score
US9457089B2Oct 4, 2016
Highly concentrated aqueous protein solution with reduced viscosity
ADOCIA13 citations84
US9278131B2Mar 8, 2016
Process for lowering the viscosity of highly concentrated protein solutions
ADOCIA9 citations77
US10610572B2Apr 7, 2020
Compositions in the form of an injectable aqueous solution including at least human insulin A21G and a glucagon suppressor with prandial action
ADOCIA2 citations73
US10583175B2Mar 10, 2020
Rapid-acting insulin formulation comprising a substituted anionic compound
ADOCIA2 citations71
US10548952B2Feb 4, 2020
Injectable solution at pH7 comprising at least one basal insulin the pI of which is from 5.8 to 8.5, a prandial insulin and/or a gastrointestinal hormone, and a co-polyamino acid bearing carboxylate charges and hydrophobic radicals
ADOCIA2 citations71
US10383920B2Aug 20, 2019
Injectable solution at pH 7 comprising at least one basal insulin the pI of which is from 5.8 to 8.5 and a co-polyamino acid bearing carboxylate charges and hydrophobic radicals
ADOCIA2 citations71
US9795678B2Oct 24, 2017
Fast-acting insulin composition comprising a substituted anionic compound and a polyanionic compound
ADOCIA3 citations71
US9700599B2Jul 11, 2017
Rapid-acting insulin formulation comprising a substituted anionic compound
ADOCIA3 citations70
US10881716B2Jan 5, 2021
Rapid-acting insulin formulation comprising a substituted anionic compound
ADOCIA1 citations69
US10646551B2May 12, 2020
Rapid-acting insulin formulation comprising a substituted anionic compound
ADOCIA3 citations69
US10485851B2Nov 26, 2019
Compositions in the form of an injectable aqueous solution comprising human glucagon and a co-polyamino acid
ADOCIA3 citations69
US9492467B2Nov 15, 2016
Rapid-acting insulin formulation comprising an oligosaccharide
ADOCIA3 citations69
US10383918B2Aug 20, 2019
Compositions in the form of an injectable aqueous solution comprising human glucagon and a statistical co-polyamino acid
ADOCIA3 citations68
US10463717B2Nov 5, 2019
Compositions in the form of an injectable aqueous solution comprising amylin, an amylin receptor agonist or an amylin analog, and a co-polyamino acid
ADOCIA3 citations67
US11065305B2Jul 20, 2021
Compositions in the form of an injectable aqueous solution including at least human insulin A21G and a glucagon suppressor with prandial action
ADOCIA1 citations62
US11191812B2Dec 7, 2021
Compositions in the form of an injectable aqueous solution comprising human glucagon and a co-polyamino acid
ADOCIA1 citations61
US10792335B2Oct 6, 2020
Rapid-acting insulin composition comprising a substituted citrate
ADOCIA1 citations60
US11633460B2Apr 25, 2023
Injectable solution at pH 7 comprising at least one basal insulin wherein the pI is comprised from 5.8 to 8.5 and a co-polyamino acid bearing carboxylate charges and hydrophobic radicals
ADOCIA2 citations59
US11324808B2May 10, 2022
Rapid-acting insulin formulation comprising a substituted anionic compound
ADOCIA0 citations59
US8367640B2Feb 5, 2013
Complex consisted of a polysaccharide and an HBP
ADOCIA3 citations58
US11707507B2Jul 25, 2023
Compositions in the form of an injectable aqueous solution comprising amylin, an amylin receptor agonist or an amylin analog, and a co-polyamino acid
ADOCIA0 citations56
US10335489B2Jul 2, 2019
Injectable solution at pH 7 comprising at least one basal insulin the pi of which is between 5.8 and 8.5 and a substituted co-polyamino acid
ADOCIA0 citations52
US9198971B2Dec 1, 2015
Injectable solution at pH 7 comprising at least one basal insulin the pI of which is between 5.8 and 8.5 and a substituted co-polyamino acid
ADOCIA0 citations52
US11576952B2Feb 14, 2023
Injectable solution at pH 7 comprising at least one basal insulin for which the pI is from 5.8 to 8.5 and a co-polyamino acid bearing carboxylate charges and hydrophobic radicals
ADOCIA0 citations51
US12186373B2Jan 7, 2025
Compositions in the form of an injectable aqueous solution comprising amylin, an amylin agonist receptor or an amylin analogue and a co-polyamino acid
ADOCIA0 citations50
US11883496B2Jan 30, 2024
Injectable pH 7 solution comprising at least one basal insulin having a pI from 5.8 to 8.5 and a co-polyamino acid bearing carboxylate charges and hydrophobic radicals
ADOCIA0 citations50
US11129877B2Sep 28, 2021
Compositions in the form of an injectable aqueous solution comprising amylin, an amylin agonist receptor or an amylin analogue and a co-polyamino acid
ADOCIA0 citations50
US11173109B2Nov 16, 2021
Compositions in the form of an injectable aqueous solution comprising amylin, an amylin receptor agonist or an amylin analog and a co-polyamino acid
ADOCIA0 citations49
US10987426B2Apr 27, 2021
Compositions in the form of an injectable aqueous solution comprising human glucagon and a co-polyamino acid
ADOCIA0 citations49
US12421327B2Sep 23, 2025
Hydrogels for cell therapy
ADOCIA0 citations46
US10525133B2Jan 7, 2020
Aqueous composition comprising at least one protein and one solubilizing agent, preparation thereof and uses thereof
ADOCIA0 citations44
US10449256B2Oct 22, 2019
Injectable solution at pH 7 comprising at least one basal insulin the isoelectric point of which is between 5.8 and 8.5 and a hydrophobized anionic polymer
ADOCIA0 citations41
US12544349B1Feb 10, 2026
Compositions comprising pemvidutide and an acylated amino acid
ADOCIA0 citations39